Condensed Consolidating Financial Statements (Details 4) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Sources (uses) of cash and cash equivalents
Net cash provided by (used in) operating activities	$ (21,524)	$ (12,145)
Investing activities:
Capital expenditures	(5,773)	(5,182)
Change in restricted cash	0	302
Proceeds from sale of assets	0	2,446
Proceeds from Divestiture of Businesses, Net of Cash Divested	0	10,125
Payments to Acquire Investments	(2,892)	0
Net cash provided by (used in) investing activities	(8,665)	7,691
Financing activities:
Proceeds from revolving line of credit	8,000	7,500
Payments of revolving line credit	(2,500)	0
Deferred acquisition payments	0	(296)
Payments on long-term debt	(481)	(2,205)
Proceeds from exercise of stock options	0	11
Payments for Repurchase of Other Equity	(544)	0
Net cash provided by (used in) financing activities	4,475	5,010
Net increase (decrease) in cash and cash equivalents	(25,714)	556
Effect of foreign currency fluctuations on cash	411	(63)
Cash and cash equivalents at beginning of fiscal period	56,362	57,929
Cash and cash equivalents at end of fiscal period	31,059	58,422
Parent
Sources (uses) of cash and cash equivalents
Net cash provided by (used in) operating activities	544	890
Investing activities:
Capital expenditures	0	0
Change in restricted cash		0
Proceeds from sale of assets		0
Proceeds from Divestiture of Businesses, Net of Cash Divested		0
Payments to Acquire Investments	0
Net cash provided by (used in) investing activities	0	0
Financing activities:
Proceeds from revolving line of credit	0	0
Payments of revolving line credit	0
Deferred acquisition payments		0
Payments on long-term debt	0	(890)
Proceeds from exercise of stock options		11
Payments for Repurchase of Other Equity	(544)
Net cash provided by (used in) financing activities	(544)	(879)
Net increase (decrease) in cash and cash equivalents	0	11
Effect of foreign currency fluctuations on cash	0	0
Cash and cash equivalents at beginning of fiscal period	640	616
Cash and cash equivalents at end of fiscal period	640	627
Guarantor Subsidiaries
Sources (uses) of cash and cash equivalents
Net cash provided by (used in) operating activities	(17,034)	(3,955)
Investing activities:
Capital expenditures	(3,912)	(115)
Change in restricted cash		302
Proceeds from sale of assets		1,513
Proceeds from Divestiture of Businesses, Net of Cash Divested		0
Payments to Acquire Investments	(2,892)
Net cash provided by (used in) investing activities	(6,804)	1,700
Financing activities:
Proceeds from revolving line of credit	6,000	7,500
Payments of revolving line credit	(2,500)
Deferred acquisition payments		(296)
Payments on long-term debt	0	0
Proceeds from exercise of stock options		0
Payments for Repurchase of Other Equity	0
Net cash provided by (used in) financing activities	3,500	7,204
Net increase (decrease) in cash and cash equivalents	(20,338)	4,949
Effect of foreign currency fluctuations on cash	0	0
Cash and cash equivalents at beginning of fiscal period	33,094	22,200
Cash and cash equivalents at end of fiscal period	12,756	27,149
Non-Guarantor Subsidiaries
Sources (uses) of cash and cash equivalents
Net cash provided by (used in) operating activities	(5,034)	(9,080)
Investing activities:
Capital expenditures	(1,861)	(5,067)
Change in restricted cash		0
Proceeds from sale of assets		933
Proceeds from Divestiture of Businesses, Net of Cash Divested		10,125
Payments to Acquire Investments	0
Net cash provided by (used in) investing activities	(1,861)	5,991
Financing activities:
Proceeds from revolving line of credit	2,000	0
Payments of revolving line credit	0
Deferred acquisition payments		0
Payments on long-term debt	(481)	(1,315)
Proceeds from exercise of stock options		0
Payments for Repurchase of Other Equity	0
Net cash provided by (used in) financing activities	1,519	(1,315)
Net increase (decrease) in cash and cash equivalents	(5,376)	(4,404)
Effect of foreign currency fluctuations on cash	411	(63)
Cash and cash equivalents at beginning of fiscal period	22,628	35,113
Cash and cash equivalents at end of fiscal period	17,663	30,646
Reclassifications and Eliminations
Sources (uses) of cash and cash equivalents
Net cash provided by (used in) operating activities	0	0
Investing activities:
Capital expenditures	0	0
Change in restricted cash		0
Proceeds from sale of assets		0
Proceeds from Divestiture of Businesses, Net of Cash Divested		0
Payments to Acquire Investments	0
Net cash provided by (used in) investing activities	0	0
Financing activities:
Proceeds from revolving line of credit	0	0
Payments of revolving line credit	0
Deferred acquisition payments		0
Payments on long-term debt	0	0
Proceeds from exercise of stock options		0
Payments for Repurchase of Other Equity	0
Net cash provided by (used in) financing activities	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Effect of foreign currency fluctuations on cash	0	0
Cash and cash equivalents at beginning of fiscal period	0	0
Cash and cash equivalents at end of fiscal period	$ 0	$ 0